CLINICAL_TRIALS
trial_result
· 2022-08-17
Clinical Trial Update: Zanubrutinib-rituximab(ZR) in Patients With Newly Diagnosed Untreated Mantle Cell Lymphoma [Phase 2]
Summary
Phase 2 trial update for Zanubrutinib combined with rituximab in patients with newly diagnosed untreated mantle cell lymphoma.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: The First Affiliated Hospital of Soochow University | Conditions: Untreated Mantle Cell Lymphoma | Phase 2 | Status: UNKNOWN